Managing Your Weight Safely: Is Wegovy Pen Single Use and How to Use It Correctly?

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes — the Wegovy injection pen is single use. Section 3 of the Wegovy prescribing information describes the product as a prefilled, disposable, single-dose pen: each pen delivers one weekly dose and is then discarded. It is not refilled, not dialed to a second dose, and not saved for the following week. That makes Wegovy structurally different from Ozempic, which is supplied in multi-dose pens, and it is one of the more common points of confusion between two products containing the same active ingredient.

What "Single-Dose Pen" Means on the Label

Most Wegovy injection presentations are single-dose pens, one per labeled strength — 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, plus the higher-strength Wegovy HD 7.2 mg pen. The label also lists single-dose syringes and one multi-dose device, the Wegovy FlexTouch single-patient-use pen (9.6 mg/3 mL), which delivers four 2.4 mg doses and can only select 2.4 mg. None of these devices has a dose dial a patient sets to an arbitrary strength; what you receive is determined by the prescription and by what the pharmacy dispenses.

Pens are supplied multiple to a carton, so a month's supply generally arrives as a set of individual pens rather than as one device. If your carton does not match what you expected, that is a pharmacy question — the dispensing label and the carton are the authoritative record of what you were given.

Why Ozempic Works Differently

Ozempic uses multi-dose, single-patient-use pens. The Ozempic label lists 3 mL prefilled pens containing semaglutide 2 mg (0.68 mg/mL), 4 mg (1.34 mg/mL), or 8 mg (2.68 mg/mL), each delivering four doses at the corresponding strength — the 8 mg/3 mL pen, for instance, delivers four doses of 2 mg. One Ozempic pen therefore covers roughly a month; one Wegovy pen covers one week.

"Single-patient-use" and "single-dose" are not synonyms, and the difference matters. A single-patient-use pen may hold several doses but must never be shared. A single-dose pen holds one dose and is discarded after it. Both categories carry the same absolute prohibition on sharing.

Never Share a Pen, Even With a New Needle

This is one of the few handling points that belongs in any article about these devices, because the risk is not obvious. Ozempic's label devotes a numbered warning section — 5.4, "Never Share an OZEMPIC Pen Between Patients" — to the point, and it specifies that this holds even if the needle is changed, because of the risk of transmitting blood-borne pathogens. The same principle applies across injectable pen devices.

There is no scenario in which sharing a pen is appropriate, including between family members with identical prescriptions. If cost is the reason someone is considering it, that is a conversation to have with a prescriber or pharmacist, who can discuss legitimate alternatives.

"Using It Correctly" Means Following the Instructions for Use

Every pen device is dispensed with an FDA-reviewed Instructions for Use document. That document is part of the labeling — it is written for the specific device, illustrated, and updated when the device changes. It covers preparation, injection sites, needle handling, disposal, and storage in a sequence designed to be followed step by step while holding the actual pen.

An article cannot replace it, and should not try. Device details differ between products and between presentations of the same product, and a generic description written for one device can be actively wrong for another. If any step in the Instructions for Use is unclear, a pharmacist will walk through it — most pharmacies will do a device demonstration on request, and many prescribers do one at the visit where therapy starts.

The same applies to storage and to what to do if a pen has been handled in a way the instructions do not cover. Those answers come from the pharmacy label and the prescriber, because they depend on the specific product and on what actually happened.

Wegovy Tablets Remove the Pen Question Entirely

Wegovy is no longer injection-only. The label now covers Wegovy tablets alongside the injection, and the tablets carry a narrower set of indications than the injection does — they do not include everything the injection is approved for. There is no device to prepare, no needle, and no injection technique to learn, but there are formulation-specific administration conditions printed on the label that differ from anything applicable to a pen.

If you are comparing options, the relevant question is not "which is easier to use" in the abstract, but which product and formulation your prescriber considers appropriate for your situation, and what each one is actually approved to treat.

Compounded Semaglutide Is a Different Category

Compounded semaglutide does not arrive as a branded Wegovy or Ozempic pen. It is prepared by a licensed pharmacy pursuant to a prescription for an individual patient, and it is dispensed in whatever presentation that pharmacy uses, with directions written for that prescription. It is not an FDA-approved finished product, and the FDA does not review compounded preparations for safety, effectiveness, or quality before they are marketed.

Practically, that means the handling instructions for a compounded preparation come from the dispensing pharmacy, not from the Wegovy Instructions for Use. It also means a compounded preparation is not a generic version of Wegovy or Ozempic — neither has an approved generic, and describing it that way misstates the regulatory status.

The Safety Conversations Worth Having

Device mechanics are the easy part of using these medications safely. The label content that deserves more attention is the clinical side: semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodents and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2. Warnings also cover acute pancreatitis, acute gallbladder disease, acute kidney injury due to volume depletion, severe gastrointestinal adverse reactions, hypersensitivity, and pulmonary aspiration during general anesthesia or deep sedation.

That last one is easy to overlook and genuinely actionable: anyone scheduled for a procedure involving anesthesia or deep sedation should make sure the team knows they are on a GLP-1 medication. It is the kind of detail that never comes up in a discussion about pens, and it matters more.

Disposal Is Part of Using It Correctly

Because each Wegovy pen is used once, therapy generates a steady stream of used devices with attached needles, and how those are discarded is a genuine safety matter rather than an afterthought. Used pens and needles are sharps. The Instructions for Use dispensed with the product covers disposal, and FDA guidance and state and local rules govern what containers and collection options are acceptable where you live.

Pharmacies are the practical resource here: many sell approved sharps containers and can point you to a local collection program. It is worth sorting out before the first pen is used rather than after a drawer has filled up, and it matters more in households with children or with anyone handling the trash.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is the Wegovy pen single use?

Usually, but not always — it depends on which presentation you were dispensed. Most Wegovy pens are prefilled, disposable, single-dose pens, one per labeled strength: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, and the higher-strength Wegovy HD 7.2 mg. Those deliver one weekly dose and are then discarded. The label also lists the Wegovy FlexTouch single-patient-use pen, which holds four 2.4 mg doses in one device. Check the carton and the Instructions for Use that came with your prescription.

How is that different from the Ozempic pen?

Ozempic uses multi-dose, single-patient-use pens: 3 mL prefilled pens containing semaglutide 2 mg, 4 mg, or 8 mg, each delivering four doses at the corresponding strength, so one pen covers roughly a month. Most Wegovy pens are single-dose and cover one week, though the label also includes the four-dose Wegovy FlexTouch pen. Single-patient-use and single-dose are not synonyms — the first describes who may use a device, the second how many doses it holds.

Can a pen ever be shared with someone else?

No. Ozempic's label devotes a numbered warning section to this, stating that a pen must never be shared between patients even if the needle is changed, because of the risk of transmitting blood-borne pathogens. The same principle applies across injectable pen devices, including single-dose pens, and it holds even between household members with identical prescriptions.

Where do the correct handling instructions come from?

From the FDA-reviewed Instructions for Use dispensed with the device, and from your pharmacist. That document is part of the labeling, written and illustrated for the specific device, and it covers preparation, injection sites, needle handling, disposal, and storage. Device details differ between products, so a generic description written for one device can be wrong for another. Most pharmacies will demonstrate on request.

Do Wegovy tablets involve a pen?

No. Wegovy is no longer injection-only — the label now covers Wegovy tablets alongside the injection. The tablets carry a narrower set of indications than the injection does, so they are not simply an oral substitute for it. There is no device or needle involved, but the tablets have formulation-specific administration conditions printed on the label that do not apply to any pen.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.